Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PeptiDream | Tokyo | Healthcare | Biotechnology & Medical Research | ¥288.71B | 19.2x | 0.05 | ¥2,207 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47% Upside | Upgrade to Pro+ | |
GNI | Tokyo | Healthcare | Biotechnology & Medical Research | ¥181.06B | 185.3x | 0.07 | ¥3,625 | 6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | |
Takara Bio | Tokyo | Healthcare | Biotechnology & Medical Research | ¥109.46B | -2,100x | 20.51 | ¥905 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanbio Company | Tokyo | Healthcare | Biotechnology & Medical Research | ¥79.15B | -26.1x | -0.49 | ¥1,115 | 5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -10.3% Downside | Upgrade to Pro+ | |
Shin Nippon Biomed Lab | Tokyo | Healthcare | Biotechnology & Medical Research | ¥67.44B | 13.7x | -1.33 | ¥1,620 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Heartseed | Tokyo | Healthcare | Biotechnology & Medical Research | ¥39.25B | -33.3x | -0.9 | ¥1,867 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Healios K K | Tokyo | Healthcare | Biotechnology & Medical Research | ¥37.47B | -8x | 0.12 | ¥386 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -19.7% Downside | Upgrade to Pro+ | |
Pharma Foods | Tokyo | Healthcare | Biotechnology & Medical Research | ¥26.64B | 8.2x | -0.23 | ¥953 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chordia Therapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | ¥18.14B | -9.6x | 0.01 | ¥272 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AnGes | Tokyo | Healthcare | Biotechnology & Medical Research | ¥17.26B | -0.5x | -0.14 | ¥62 | 8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
3-D Matrix | Tokyo | Healthcare | Biotechnology & Medical Research | ¥17.26B | -15.8x | -0.27 | ¥173 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MediciNova | Tokyo | Healthcare | Biotechnology & Medical Research | ¥14.66B | -9.4x | 1.45 | ¥296 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chiome Bioscience | Tokyo | Healthcare | Biotechnology & Medical Research | ¥13.12B | -7x | 0.64 | ¥195 | -4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tsubota Laboratory | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.97B | 28.6x | 0.2 | ¥422 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NanoCarrier | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.94B | -17.2x | -1.4 | ¥157 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PRISM BioLab | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.64B | ¥307 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
TMS | Tokyo | Healthcare | Biotechnology & Medical Research | ¥10.57B | -7.4x | 0.2 | ¥256 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medinet | Tokyo | Healthcare | Biotechnology & Medical Research | ¥9.52B | -1.4x | ¥36 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
NoileImmune Biotech | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.88B | -8.2x | -0.35 | ¥185 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D.Western Therapeutics Institute | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.83B | -4.9x | 0.1 | ¥184 | 29.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Linical Co Ltd | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.7B | -33.5x | 0.57 | ¥341 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.6% Upside | Upgrade to Pro+ | |
OncoTherapy | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.61B | -6.8x | -0.27 | ¥29 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Chip Research | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.39B | -208x | -2.39 | ¥1,092 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cyfuse Biomedical KK | Tokyo | Healthcare | Biotechnology & Medical Research | ¥7.18B | -8.4x | -1.19 | ¥868 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Modalis | Tokyo | Healthcare | Biotechnology & Medical Research | ¥6.94B | -3.5x | -0.07 | ¥101 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Carna Biosciences | Tokyo | Healthcare | Biotechnology & Medical Research | ¥6.13B | -2.6x | 0.03 | ¥321 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Veritas In Silico | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.61B | -34.3x | ¥880 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kringle | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.51B | -6.8x | -0.29 | ¥792 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kidswell Bio | Tokyo | Healthcare | Biotechnology & Medical Research | ¥5.49B | -7.8x | ¥137 | 10.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Funpep | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.89B | -4.7x | -0.29 | ¥159 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ribomic | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.59B | -4.3x | -0.49 | ¥109 | 6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Human Metabolome Tech | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.2B | 15.8x | -2.29 | ¥708 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BrightPath Biotherapeutics | Tokyo | Healthcare | Biotechnology & Medical Research | ¥4.02B | -1x | ¥45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
PhoenixBio Co | Tokyo | Healthcare | Biotechnology & Medical Research | ¥1.42B | -10.3x | 0.06 | ¥351 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |